Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies.
作者信息
Pincez Thomas, Bruneau Julie, Berteloot Laureline, Piekarski Eve, Thomas Caroline, Marçais Ambroise, Trinquand Amélie, Castelle Martin, Garcelon Nicolas, Plantaz Dominique, Cheminant Morgane, Moshous Despina, Molina Thierry Jo, Hermine Olivier, Macintyre Elizabeth, Fischer Alain, Blanche Stéphane, Suarez Felipe, Neven Bénédicte
机构信息
Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris.
Pathology Department, Hôpital Necker-Enfants Malades, AP-HP, Paris; Paris University, Paris; INSERM UMR 1163, Institut Imagine, Paris.
出版信息
Haematologica. 2020 Sep 1;105(9):e461-464. doi: 10.3324/haematol.2019.230276.
Abstract
摘要
Zotero 插件